share_log

12 Health Care Stocks Moving In Thursday's After-Market Session

Benzinga ·  Jun 21 04:31

Gainers

  • Psyence Biomedical (NASDAQ:PBM) stock moved upwards by 68.1% to $1.0 during Thursday's after-market session. The market value of their outstanding shares is at $13.3 million.
  • Kintara Therapeutics (NASDAQ:KTRA) shares moved upwards by 15.67% to $0.32. The market value of their outstanding shares is at $17.5 million.
  • Talphera (NASDAQ:TLPH) shares rose 12.64% to $0.92. The market value of their outstanding shares is at $15.6 million.
  • Helius Medical Tech (NASDAQ:HSDT) shares moved upwards by 10.11% to $1.06. The market value of their outstanding shares is at $3.1 million.
  • Clover Health Investments (NASDAQ:CLOV) stock rose 9.72% to $1.13. The company's market cap stands at $561.0 million.
  • Ensysce Biosciences (NASDAQ:ENSC) shares increased by 8.77% to $0.6. The company's market cap stands at $4.5 million.

Losers

  • Kineta (NASDAQ:KA) stock fell 8.1% to $0.59 during Thursday's after-market session. The company's market cap stands at $7.2 million.
  • Clene (NASDAQ:CLNN) shares fell 4.99% to $0.37. The company's market cap stands at $47.7 million.
  • Alzamend Neuro (NASDAQ:ALZN) shares declined by 4.86% to $0.39. The market value of their outstanding shares is at $2.8 million.
  • SenesTech (NASDAQ:SNES) stock fell 4.28% to $0.59. The market value of their outstanding shares is at $3.0 million.
  • Portage Biotech (NASDAQ:PRTG) stock decreased by 4.26% to $0.27. The market value of their outstanding shares is at $5.3 million.
  • Trevena (NASDAQ:TRVN) shares fell 4.07% to $0.24. The market value of their outstanding shares is at $4.3 million.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment